This page lists the SEC filings reported by Kynam Capital Management, LP.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2024-03-08 | Kynam Capital Management, LP | MorphoSys AG | 4,190,331 | 11.1% | EDGAR |
| SC 13G/A | 2024-02-14 | Kynam Capital Management, LP | Burning Rock Biotech Ltd | 8,694,426 | 10.2% | EDGAR |
| SC 13G/A | 2024-02-14 | Kynam Capital Management, LP | Vera Therapeutics, Inc. | 3,650,339 | 8.2% | EDGAR |
| SC 13G/A | 2024-02-14 | Kynam Capital Management, LP | Olema Pharmaceuticals, Inc. | 0 | 0.0% | EDGAR |
| SC 13G | 2024-02-14 | Kynam Capital Management, LP | MorphoSys AG | 3,690,331 | 9.8% | EDGAR |
| SC 13G | 2024-02-14 | Kynam Capital Management, LP | Syndax Pharmaceuticals Inc | 5,660,000 | 6.7% | EDGAR |
| SC 13G | 2024-02-14 | Kynam Capital Management, LP | Cogent Biosciences, Inc. | 5,854,766 | 6.8% | EDGAR |
| SC 13G | 2024-02-14 | Kynam Capital Management, LP | Celldex Therapeutics, Inc. | 3,005,904 | 5.5% | EDGAR |
| SC 13G | 2024-01-10 | Kynam Capital Management, LP | Burning Rock Biotech Ltd | 8,694,426 | 10.2% | EDGAR |
| SC 13G | 2023-09-06 | Kynam Capital Management, LP | 2seventy bio, Inc. | 5,142,111 | 10.1% | EDGAR |
| SC 13G/A | 2023-03-22 | Kynam Capital Management, LP | Olema Pharmaceuticals, Inc. | 2,025,234 | 5.0% | EDGAR |
| SC 13G | 2023-02-10 | Kynam Capital Management, LP | Burning Rock Biotech Ltd | 7,391,581 | 8.4% | EDGAR |
| SC 13G | 2023-02-10 | Kynam Capital Management, LP | CONCERT PHARMACEUTICALS, INC. | 4,420,349 | 9.2% | EDGAR |
| SC 13G | 2023-02-10 | Kynam Capital Management, LP | Olema Pharmaceuticals, Inc. | 40,423,832 | 5.0% | EDGAR |
| SC 13G | 2023-02-10 | Kynam Capital Management, LP | Vera Therapeutics, Inc. | 1,409,098 | 5.1% | EDGAR |
| SC 13G | 2023-02-10 | Kynam Capital Management, LP | CONCERT PHARMACEUTICALS, INC. | 4,420,349 | 9.2% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.